XML 60 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Instruments
3 Months Ended
Jun. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Derivative Instruments

The Company uses derivative instruments to manage selected foreign currency exposures. The Company does not use derivative instruments for speculative trading purposes. All derivative instruments must be recorded on the balance sheet at fair value. For derivatives designated as cash flow hedges, the effective portion of changes in the fair value of the derivative is recorded as accumulated other comprehensive gain (loss), or “AOCL,” and is reclassified to earnings when the underlying transaction has an impact on earnings. The ineffective portion of changes in the fair value of the derivative is reported in foreign currency exchange (gain) loss in the Company’s condensed consolidated statement of operations and retained earnings. For derivatives not classified as cash flow hedges, all changes in market value are recorded as a foreign currency exchange (gain) loss in the Company’s condensed consolidated statements of operations and retained earnings. The cash flow effects of derivatives are reported within net cash provided by operating activities.

The Company has foreign currency forward agreements in place to hedge changes in the value of recorded foreign currency assets and liabilities due to changes in foreign exchange rates at the settlement date. The notional amount of those derivatives is $3,515,000 and all contracts mature within five months. These contracts are marked to market each balance sheet date and are not designated as hedges.

The Company has foreign currency forward agreements that are designated as cash flow hedges to hedge a portion of forecasted inventory purchases denominated in a foreign currency. The notional amount of those derivatives is $2,179,000 and all contracts mature within eleven months of June 30, 2014.

The Company is exposed to credit losses in the event of non performance by the counterparties on its financial instruments. All counterparties have investment grade credit ratings. The Company anticipates that these counterparties will be able to fully satisfy their obligations under the contracts. The Company has derivative contracts with two counterparties as of June 30, 2014.

The Company's agreements with its foreign exchange contract counterparties contain provisions pursuant to which the Company could be declared in default of its derivative obligations. As of June 30, 2014, the Company had not posted any collateral related to these agreements. If the Company had breached any of these provisions as of June 30, 2014, it could have been required to settle its obligations under these agreements at amounts which approximate the June 30, 2014 fair values reflected in the table below. During the three months ended June 30, 2014, the Company was not in default of any of its derivative obligations.

From its June 30, 2014 balance of accumulated other comprehensive loss, the Company expects to reclassify approximately $83,000 out of accumulated other comprehensive loss during the next 12 months.

The following is the effect of derivative instruments on the condensed consolidated statements of operations and retained earnings for the three months ended June 30, 2014 and 2013 (in thousands):

June 30,
 
Derivatives Designated as Cash Flow  Hedges (Foreign Exchange Contracts)
 
Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives (Effective Portion)
 
Location of Gain or (Loss) Recognized in Income on Derivatives
 
Amount of Gain or (Loss) Reclassified from AOCL into Income (Effective Portion)
2014
 
Foreign exchange contracts
 
$
3

 
Cost of products sold
 
$
(113
)
2013
 
Foreign exchange contracts
 
91

 
Cost of products sold
 
5


June 30,
Derivatives Not Designated as Hedging Instruments (Foreign Exchange Contracts)
Location of Gain (Loss) Recognized in Income on Derivatives
Amount of Gain (Loss) Recognized in Income on Derivatives
2014
Foreign exchange contracts
Foreign currency exchange loss
$
(42
)
2013
Foreign exchange contracts
Foreign currency exchange gain
130



As of June 30, 2014, the Company had no derivatives designated as net investments or fair value hedges in accordance with ASC Topic 815, “Derivatives and Hedging.”


The following is information relative to the Company’s derivative instruments in the condensed consolidated balance sheets as of June 30, 2014 (in thousands):

 
 
 
 
Fair Value of Asset (Liability)
Derivatives Designated as Hedging Instruments
 
Balance Sheet Location
 
June 30, 2014
 
March 31,
2014
Foreign exchange contracts
 
Other Assets
 
$

 
$

Foreign exchange contracts
 
Accrued Liabilities
 
$
(71
)
 
$
(141
)
 
 
 
 
 
 
 
Derivatives Not Designated as Hedging Instruments
 
Balance Sheet Location
 
June 30, 2014
 
March 31,
2014
Foreign exchange contracts
 
Other Assets
 
$
96

 
$
163

Foreign exchange contracts
 
Accrued Liabilities
 
$
(21
)
 
$
(64
)